Bruker Corp. (NASDAQ:BRKR) CEO Frank H. Laukien acquired 2,124 shares of the stock in a transaction on Friday, November 25th. The shares were acquired at an average price of $22.90 per share, with a total value of $48,639.60. Following the transaction, the chief executive officer now directly owns 37,699,606 shares of the company’s stock, valued at $863,320,977.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Bruker Corp. (NASDAQ:BRKR) opened at 22.68 on Thursday. The stock has a 50 day moving average of $21.80 and a 200-day moving average of $23.16. The stock has a market cap of $3.63 billion, a P/E ratio of 25.63 and a beta of 1.04. Bruker Corp. has a 12 month low of $19.58 and a 12 month high of $29.85.

Bruker Corp. (NASDAQ:BRKR) last posted its earnings results on Wednesday, November 2nd. The company reported $0.32 EPS for the quarter, beating the Zacks’ consensus estimate of $0.20 by $0.12. Bruker Corp. had a net margin of 9.02% and a return on equity of 26.05%. The company had revenue of $393.90 million for the quarter, compared to analysts’ expectations of $394.14 million. During the same quarter in the prior year, the company posted $0.19 earnings per share. Bruker Corp.’s revenue for the quarter was down .6% compared to the same quarter last year. On average, equities analysts forecast that Bruker Corp. will post $1.10 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 23rd. Shareholders of record on Monday, December 5th will be given a $0.04 dividend. The ex-dividend date of this dividend is Thursday, December 1st. This represents a $0.16 dividend on an annualized basis and a yield of 0.71%. Bruker Corp.’s payout ratio is currently 18.18%.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Financial Market News and is owned by of Financial Market News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this report can be read at http://www.financial-market-news.com/bruker-corp-brkr-ceo-purchases-48639-60-in-stock/1212304/.

Several research firms have commented on BRKR. Leerink Swann began coverage on shares of Bruker Corp. in a research report on Thursday, November 10th. They set a “market perform” rating and a $21.00 price objective for the company. Zacks Investment Research upgraded shares of Bruker Corp. from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a report on Monday, November 7th. Cantor Fitzgerald restated a “buy” rating and issued a $28.00 target price on shares of Bruker Corp. in a report on Thursday, November 3rd. Barclays PLC lowered their target price on shares of Bruker Corp. from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Wednesday, August 3rd. Finally, Morgan Stanley set a $23.00 target price on shares of Bruker Corp. and gave the stock a “hold” rating in a report on Wednesday, August 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Bruker Corp. has a consensus rating of “Hold” and a consensus price target of $25.73.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. GSA Capital Partners LLP boosted its position in Bruker Corp. by 86.0% in the second quarter. GSA Capital Partners LLP now owns 150,990 shares of the company’s stock worth $3,434,000 after buying an additional 69,804 shares during the last quarter. Old Mutual Global Investors UK Ltd. boosted its position in Bruker Corp. by 127.0% in the second quarter. Old Mutual Global Investors UK Ltd. now owns 310,063 shares of the company’s stock worth $7,050,000 after buying an additional 173,485 shares during the last quarter. Acadian Asset Management LLC boosted its position in Bruker Corp. by 78.2% in the second quarter. Acadian Asset Management LLC now owns 6,243,776 shares of the company’s stock worth $141,986,000 after buying an additional 2,740,421 shares during the last quarter. GW&K Investment Management LLC boosted its position in Bruker Corp. by 13.2% in the second quarter. GW&K Investment Management LLC now owns 104,408 shares of the company’s stock worth $2,374,000 after buying an additional 12,194 shares during the last quarter. Finally, Thompson Rubinstein Investment Management Inc. OR boosted its position in Bruker Corp. by 0.8% in the second quarter. Thompson Rubinstein Investment Management Inc. OR now owns 172,300 shares of the company’s stock worth $3,918,000 after buying an additional 1,370 shares during the last quarter. 67.74% of the stock is currently owned by institutional investors.

Bruker Corp. Company Profile

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

5 Day Chart for NASDAQ:BRKR

Receive News & Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.